Clinical Trials on Systemic Mastocytosis With an Associated Hematological Neoplasm
Total 6646 results
-
H. Lee Moffitt Cancer Center and Research InstituteBlueprint Medicines CorporationRecruitingSystemic Mastocytosis With an Associated Hematologic NeoplasmUnited States
-
Blueprint Medicines CorporationAnalysis Group, Inc.CompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematological NeoplasmUnited States, Austria, Germany, Spain, United Kingdom
-
Blueprint Medicines CorporationActive, not recruitingMast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic NeoplasmUnited States, Canada, United Kingdom, France, Netherlands, Italy, Spain, Austria, Denmark, Germany, Norway, Poland
-
Novartis PharmaceuticalsAvailableAcute Myeloid Leukemia | Mast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic Neoplasm | FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia
-
Cogent Biosciences, Inc.RecruitingAdvanced Systemic Mastocytosis (AdvSM) | SM With an Associated Hematologic Neoplasm (SM-AHN) | Mast Cell Leukemia (MCL) | Aggressive Systemic Mastocytosis (ASM)Norway, United States, Spain, Australia, United Kingdom, Switzerland, Germany, Belgium, Netherlands, Canada, France, Austria, Italy
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Blueprint Medicines CorporationCompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease | Relapsed or Refractory Myeloid MalignanciesUnited States, United Kingdom
-
Joseph ButterfieldTerminatedCutaneous MastocytosesUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingSystemic Mastocytosis With AHNMD | Acute Myeloid Leukemia With T(8;21)(Q22;Q22)China
-
Blueprint Medicines CorporationRecruitingAdvanced Systemic MastocytosisUnited States, Norway, Netherlands, Belgium, Germany, France, Spain
-
University Hospital, ToulouseNot yet recruiting
-
Foundation For Rare Disease ResearchInstitute for Asthma & Allergy; Virant Diagnostics, Inc.; MedBio Reference Laboratories...Not yet recruitingAngioedema | Urticaria | C1 Inhibitor Deficiency | Angioedemas, Hereditary | Mastocytosis | Indolent Systemic Mastocytosis | Systemic Mastocytoses | ACE Inhibitor-Induced Angioedema
-
Blueprint Medicines CorporationActive, not recruitingIndolent Systemic MastocytosisCanada, United States, Spain, United Kingdom, Germany, Belgium, Switzerland, Italy, Netherlands, Denmark, France, Norway, Sweden
-
Telios Pharma, Inc.RecruitingMyelofibrosis | Indolent Systemic MastocytosisUnited States, Spain, Belgium, Australia, Taiwan, Germany, Poland, Korea, Republic of, Hungary, Brazil, Bulgaria, France, Italy
-
Assistance Publique - Hôpitaux de ParisUnknownPatients With an Indication for Myomectomy or Polymyomectomy
-
AB ScienceRecruitingIndolent Systemic MastocytosisFrance, Netherlands, Germany, United Kingdom, Russian Federation, Poland, Romania, Ukraine
-
Astellas Pharma Global Development, Inc.WithdrawnSubjects With NSCLC With an EGFR Activating Mutation
-
University Hospital, ToulouseRecruitingMastocytosis, Indolent SystemicFrance
-
University Hospital, ToulouseCompletedIndolent Systemic Mastocytosis | Cutaneous MastocytosisFrance
-
IRCCS Policlinico S. MatteoItalian Association for Pediatric Hematology OncologyUnknownPaediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated VolunteerItaly
-
Allakos Inc.CompletedIndolent Systemic MastocytosisGermany
-
Jason Robert GotlibNovartis; Novartis PharmaceuticalsCompletedSystemic Mastocytosis, Aggressive (ASM) | Leukemia, Mast Cell | Hematological Non-mast Cell Lineage Disease (AHNMD)United States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Hospital Virgen de la SaludUnknown
-
Patara PharmaCompletedSystemic Mastocytosis | Mastocytosis | Indolent Systemic MastocytosisFrance, Germany, Spain, Italy, Netherlands
-
University Medical Center GroningenUnknown
-
Cogent Biosciences, Inc.RecruitingMastocytosis | Mastocytosis, Systemic | SSM | Mastocytosis, IndolentUnited States, Italy, Canada, Australia, Spain, Switzerland, Norway, United Kingdom, Belgium, Poland, Netherlands, Germany, France, Czechia, Greece, Ireland
-
AB ScienceCompletedIndolent Systemic MastocytosisFrance, United States
-
National Institute of Allergy and Infectious Diseases...CompletedIndolent Systemic MastocytosisUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedSystemic MastocytosisUnited States
-
Jason Robert GotlibNational Cancer Institute (NCI)TerminatedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedPatients With Advanced Lymphoid Malignancies in the Absence of an HLA Identical or Mismatch DonorFrance
-
Glicksman, Caroline, M.D.The Aesthetic Surgery Education & Research FoundationActive, not recruitingWomen With Breast Implants With and Without Self-reported Systemic Symptoms | Women Undergoing an Elective Mastopexy (Breast Lift) or Small ReductionUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Systemic MastocytosisUnited States
-
University Hospital, ToulouseCompletedSystemic MastocytosisFrance, Martinique
-
Hospital Virgen de la SaludCompleted
-
Federico II UniversityUniversity of BolognaUnknown
-
Blueprint Medicines CorporationRecruitingIndolent Systemic Mastocytosis | Monoclonal Mast Cell Activation SyndromeUnited States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
-
M.D. Anderson Cancer CenterGemin XTerminated
-
Harpoon TherapeuticsCompletedAdvanced Cancers Associated With Mesothelin ExpressionUnited States
-
Uppsala UniversityKarolinska InstitutetRecruitingMastocytosis, SystemicSweden
-
Jason Robert GotlibSeagen Inc.CompletedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Novartis PharmaceuticalsCompletedLeukemiaUnited States, Belgium, Netherlands, Canada, Austria, Germany, Australia, United Kingdom, Turkey, France, Poland, Norway
-
Adelphi Values LLCBlueprint Medicines CorporationCompletedMast Cell Leukemia (MCL) | Aggressive Systemic Mastocytosis (ASM) | SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD) | Smoldering Systemic Mastocytosis (SSM) | Indolent Systemic Mastocytosis (ISM) ISM Subgroup Fully RecruitedUnited States
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la LoireCompletedHematological Malignancies Treated With Intensive ChemotherapyFrance
-
Assistance Publique - Hôpitaux de ParisCEREMASTCompletedOsteoporosis | Systemic MastocytosisFrance
-
University Hospital, ToulouseUnknown
-
JADO Technologies GmbHCompleted